| Update in treatment of pulmonary sarcoidosis | Elif BABAOĞLU | 137–144 |
| Effects of dietary intervention on diet inflammatory index and asthma characteristics in obese asthmatic individuals: Randomized controlled trial | Aslı UÇAR, Dilşad MUNGAN, Zeynep MISIRLIGİL, Ümüş Özbey YÜCEL, Zeynep ÇELEBİ SÖZENER, Serap BALABAN, Nitin SHİVAPPA, James R. HEBERT | 145–151 |
| Evaluation of Nicotine Dependence Level and Factors Affecting the Success of Smoking Cessation in an Outpatient Clinic | Müşerref Şule AKÇAY, Cihan FİDAN, Funda SALGÜR, Meliha Kübra ŞİMŞEK, Şeyma Berfu BİRLİK | 152–158 |
| Temperament and character profile assessment of anxiety and depression in tuberculosis patients | Fulsen BOZKUŞ, Fatma Özlem ORHAN, Selma ATEŞ, Anıl SAMUR | 159–165 |
| Microorganisms resistant to conventional antibiotics therapy in hospitalized patients with severe acute exacerbation of chronic obstructive pulmonary disease | Manal R HAFEZ, Heba H ELTRAWY, Hala YM ABDEN | 166–173 |
| The usefulness of Palliative Prognostic Index in predicting the survival of patients with advanced lung cancer | Gülfidan ARAS, Funda SEÇKİN AKIN | 174–179 |
| Evaluation of the serum pentraxin 3 levels in patients with stable asthma | Çiğdem YENİSEY, Onur YAZICI, Şule TAŞ GÜLEN | 180–184 |
| Analysis of emergency department admissions of a chest diseases hospital during the early period of SARS-CoV-2 outbreak | Yasemin SÖYLER, Feza UĞURMAN | 185–190 |
| A case of immunoglobulin G4‑related lung disease with normal serum immunoglobulin G4 level and hybrid radiological findings | Veli YAZISIZ, Hülya DİROL, İrem Hicran ÖZBUDAK | 191–194 |
| Covid-19 Cases Developing Dyspnea Under Anticoagulant Treatment | Füsun FAKILI, Nur PALAZ, Nazan Gülhan BAYRAM | 195–197 |